We are delighted to inform of the nomination of Prof. Ruth Ladenstein, CCRI Austria, ERN PaedCan Coordinator and SIOP Europe Board Member, to the Mission Board for Cancer, which will support the European Commission in the development of a brand new initiative focusing on optimizing cancer research under the EU 9th Framework Programme for Research and Innovation (2021 – 2027), Horizon Europe.
Cancer was defined as a mission area where targeted initiatives will be defined to achieve tangible goals with high societal relevance over the next years.
The advisory group is composed of 15 cancer experts representing a variety of disciplines and is chaired by Prof. Harald zur Hausen, Nobel Prize Laureate in Physiology and Medicine.
See here the full group composition (pages 2-3).
We wish Prof. Ladenstein all the very best in this important role.